TG Therapeutics | TGTX - Créanciers Commerciaux





Créanciers Commerciaux Changement Date
AbbVie USD 3.59B 28.65B 2025-12
Alaunos Therapeutics USD 400K 213K 2026-03
Amgen USD 2.86B 16.65B 2026-06
Ardelyx USD 28.2M 8.96M 2026-03
Arrowhead Research USD 27.78M 2.97M 2026-06
Bayer EUR 6.39B 192M 2026-06
Biogen USD 403.9M 45.4M 2026-06
Corcept Therapeutics USD 14.91M 18.4M 2026-06
Curis USD 6.74M 1.13M 2026-03
Gilead Sciences USD 645M 70M 2026-03
J&J USD 9.22B 1.24B 2026-06
Karyopharm Therapeutics USD 4.28M 276K 2026-03
Novartis USD 4.26B 64M 2026-06
Novavax USD 22.94M 6.84M 2026-06
PTC Therapeutics USD 40.45M 14.96M 2026-06
Puma Biotechnology USD 6.39M 962K 2025-09
Regeneron Pharmaceuticals USD 1.16B 132.2M 2026-06
Roche Holding CHF 5.54B 237M 2026-06
TG Therapeutics USD 213.69M 64.85M 2026-06
Verastem USD 9.6M 2.85M 2026-03
Vertex Pharmaceuticals USD 3.61B 135M 2026-06